Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)-deficient non-squamous non-small cell lung cancer.

被引：0
|
作者：
Wimalasingham, Akhila Ganeshi
Phillips, Melissa Mary
Lim, Louise
Rashid, Sukaina
Hall, Peter Edward
Khadeir, Ramsay
Steele, Jeremy P. C.
Conibear, John
Feng, Xiaoxing
Ellis, Stephen
Chan, Pui Ying
Thomson, Jim
Johnston, Amanda L.
Bomalaski, John S.
Pacey, Simon
Sheaff, Michael
Szlosarek, Peter Wojciech
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Barts Canc Inst, London, England
[3] Queen Mary Univ London, London, England
[4] St Bartholomews Hosp, London, England
[5] Washington State Univ, Pullman, WA 99164 USA
[6] Barts Hlth Trust, London, England
[7] Polaris Pharmaceut Inc, San Diego, CA USA
[8] Agouron Pfizer, San Diego, CA USA
[9] Univ Cambridge, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9097
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer
    Szlosarek, Peter W.
    Wimalasingham, Akhila G.
    Phillips, Melissa M.
    Hall, Peter E.
    Chan, Pui Ying
    Conibear, John
    Lim, Louise
    Rashid, Sukaina
    Steele, Jeremy
    Wells, Paula
    Shiu, Chiung-Fang
    Kuo, Chih-Ling
    Feng, Xiaoxing
    Johnston, Amanda
    Bomalaski, John
    Ellis, Stephen
    Grantham, Marianne
    Sheaff, Michael
    CANCER MEDICINE, 2021, 10 (19): : 6642 - 6652
  • [2] Expansion study of pegylated arginine deiminase (ADI-PEG20), pemetrexed, and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer (TRAP)
    Phillips, Melissa
    Szyszko, Teresa
    Hall, Peter
    Rashid, Sukaina
    Khadeir, Ramsay
    Lim, Louise
    Steele, Jeremy
    Conibear, John
    Wells, Paula
    Ellis, Stephen
    Feng, Xiaoxing
    Thomson, Jim
    Johnston, Amanda
    Wu, Bor-Wen
    Bomalaski, John
    Pacey, Simon
    Cook, Gary
    Szlosarek, Peter
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [3] Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers
    Beddowes, Emma
    Spicer, James
    Chan, Pui Ying
    Khadeir, Ramsay
    Corbacho, Javier Garcia
    Repana, Dimitra
    Steele, Jeremy P.
    Schmid, Peter
    Szyszko, Teresa
    Cook, Gary
    Diaz, Monica
    Feng, Xiaoxing
    Johnston, Amanda
    Thomson, Jim
    Sheaff, Michael
    Wu, Bor-Wen
    Bomalaski, John
    Pacey, Simon
    Szlosarek, Peter W.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) : 1778 - +
  • [4] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [5] Phase I study of ADI-PEG 20 in combination with pemetrexed and cisplatin (TRAP) in patients with ASS1-deficient mesothelioma and non-squamous lung cancer.
    Szlosarek, Peter Wojciech
    Spicer, James F.
    Szyszko, Teresa
    Cook, Gary J. R.
    Chan, Pui Ying
    Hategan, Mirela
    Repana, Dimitra
    Steele, Jeremy Peter
    Schmid, Peter
    Diaz, Monica
    Johnston, Amanda
    Sheaff, Michael
    Khadeir, Ramsay
    Bomalaski, John S.
    Pacey, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] A Phase I Study of Pegylated Arginine Deiminase ( Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma
    Hall, Peter E.
    Lewis, Rachel
    Syed, Nelofer
    Shaffer, Richard
    Evanson, Jane
    Ellis, Stephen
    Williams, Matthew
    Feng, Xiaoxing
    Johnston, Amanda
    Thomson, Jim A.
    Harris, Fiona P.
    Jena, Raj
    Matys, Tomasz
    Jefferies, Sarah
    Smith, Kate
    Wu, Bor-Wen
    Bomalaski, John S.
    Crook, Timothy
    O'Neill, Kevin
    Paraskevopoulos, Dimitris
    Khadeir, Ramsay S.
    Sheaff, Michael
    Pacey, Simon
    Plowman, Piers N.
    Szlosarek, Peter W.
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2708 - 2716
  • [7] Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan
    Asami, Kazuhiro
    Kawahara, Masaaki
    Hirashima, Tomonori
    Suzuki, Hidekazu
    Okishio, Kyoichi
    Omachi, Naoki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hirooka, Aya
    Nakao, Keiko
    Tsuji, Taisuke
    Atagi, Shinji
    THORACIC CANCER, 2014, 5 (04) : 289 - 296
  • [8] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [9] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [10] Pegylated arginine deiminase sensitizes ASS1-negative and KRAS mutant non-small cell lung cancer to PD-1 blockade immunotherapy
    Pavlyk, Iuliia
    Foster, Julie
    Dexter, Katie
    Sobasowski, Jane
    Bomalarski, John
    Berlato, Chiara
    Balkwill, Frances
    Szlosarek, Peter W.
    CANCER RESEARCH, 2020, 80 (16)
12345